14-3-3ζ interacts with DNA-binding domain of FOXO3a and competitively dissociates DNA by dual-motif tethering
In cancer cells, Ras protein mutations activate a signaling cascade that phosphorylates kinases, transcription, and translation factors, driving cancer cell proliferation. One such factor, FOXO3a, promotes apoptosis-related gene transcription. However, in many cancer cells, FOXO3a is phosphorylated and is bound to 14-3-3ζ at phosphorylation sites. The 14-3-3ζ binding displaces phosphorylated FOXO3a from DNA, suppressing apoptosis. Since the phosphorylation sites are far from the DNA-binding domain (DBD) of FOXO3a, the mechanism of displacement remains unclear. Using isothermal titration calorimetry and fluorescence-detection size-exclusion chromatography, we find that 14-3-3ζ strongly displaces DNA from di-phosphorylated FOXO3a (dpFOXO3a), despite similar dissociation constants for dpFOXO3a-14-3-3ζ and dpFOXO3a-DNA. Nuclear magnetic resonance data identify weak, but direct binding of 14-3-3ζ to the DBD, suggesting direct competition. These findings suggest that 14-3-3ζ enhances its competitive ability by dual tethering to the DBD of FOXO3a via phosphorylation sites, effectively displacing DNA.
Authors
- Mariko Yokogawa (ORCID: https://orcid.org/0000-0003-3448-7112)
- Mikio Tanabe (ORCID: https://orcid.org/0000-0002-4096-6075)
- Hideyuki Saya (ORCID: https://orcid.org/0000-0001-6610-1902)
- Masanori Osawa (ORCID: https://orcid.org/0000-0002-1285-4316)
- Toshiya Senda (ORCID: https://orcid.org/0000-0002-5153-928X)
- Tomomi Kimura (ORCID: https://orcid.org/0000-0002-3260-8104)
- Kosaku Kawatsu
- Jun Saito
- Tomoya Kuwayama
- Risa Nakamura
- Shota Enomoto
- Shoichi Nakatsuka
Institutions
- High Energy Accelerator Research Organization (JP)
- Keio University (JP)
- Fujita Health University Hospital (JP)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1038/s41467-026-69203-8
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science